Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lumosa Therapeutics Announces Positive Results from Phase 2 Stroke Clinical Trial

americanpharmaceuticalreviewAugust 04, 2021

Tag: Lumosa , stroke , LT3001 , AIS

PharmaSources Customer Service